U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07725601) titled 'VNS Algorithm for Advanced Dosing' on July 21.
Brief Summary: The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is:
Does the modified programming of the VNS reduce seizures faster than the standard programming?
Participants in both groups will:
1. Attend up to 3 study visits every 3 months for 2 years
2. Answer questionnaires to assess quality of life and cognitive function
3. Maintain a diary of seizure activity
Study Start Date: Aug. 01, 2025
Study Type: INTERVENTIONAL
Condit...